Title | A Phase 3, Open-Label, Randomized Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Patients With Previously Untreated Chronic Lymphocytic Leukemia |
Protocole ID | BGB-11417-301 |
ClinicalTrials.gov ID | NCT06073821 |
Cancer Type(s) | Chronic Lymphocytic Leukemia |
Phase | Phase III |
Stage | |
Study Type | Clinical |
Drug | Sonrotoclax + zanubrutinib comparé à vénétoclax + obinutuzumab |
Institution |
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS 1401 18e Rue, Québec, QC, G1J 1Z4 |
City | |
Principal Investigator |
Dr. Jean-François Larouche |
Coordinator |
Philippe Nadeau 418-649-0252 poste 63115 |
Status | Recruiting |
Activation Date | 19-02-2024 |
Eligibility Criteria |
|
Exclusion Criteria |
|